Loading clinical trials...
Loading clinical trials...
This was a randomized, double-blind, placebo-controlled, ascending single dose safety, tolerability, and pharmacokinetic study of orally administered EDP-322. This study was conducted at a single site...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Enanta Pharmaceuticals, Inc
NCT05632315 · Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, and more
NCT01209234 · Methicillin-resistant Staphylococcus Aureus
NCT04171817 · Methicillin-resistant Staphylococcus Aureus, Clostridium Difficile, and more
NCT05529173 · Surgical Wound Infection, Preoperative Care, and more
NCT02814916 · Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, and more
PPD Phase I Unit
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions